National Bank of Canada
TEVA icon

National Bank of Canada’s Teva Pharmaceuticals TEVA Stock Holding History

National Bank of Canada’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,000
Closed -$6.02M – 3332
2026
Q1 		$6.02M Buy
2,000
+200
+11% +$6.43K 0.01% 814
2025
Q4 		$5.62M Hold
1,800
– – 0.01% 853
2025
Q3 		$3.64M Buy
+1,800
New +$31.6K ﹤0.01% 949
2022
Q3 		– Sell
-19,000
Closed -$14.3M – 2893
2022
Q2 		$14.3M Buy
+19,000
New +$166K 0.07% 317

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.63B AUM 45.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $2.44B AUM 24.95% 1-Year Est. Return

National Bank of Canada's TEVA Position: Q2 2026 in Review

National Bank of Canada reduced its Teva Pharmaceuticals (TEVA) stake by 40% in Q2 2026, selling an estimated $6.34M and leaving 282,227 shares worth $9.56M. The position accounts for 0.01% of the portfolio, ranked #756.

National Bank of Canada first reported a position in TEVA in Q4 2021 and has held it in 19 quarters since. The position peaked at $28.8M in Q4 2025. 363 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • National Bank of Canada held 282,227 shares of Teva Pharmaceuticals worth $9.56M as of Q2 2026.
  • National Bank of Canada sold 190,445 Teva Pharmaceuticals shares in Q2 2026, an estimated $6.34M.
  • Teva Pharmaceuticals made up 0.01% of National Bank of Canada's portfolio in Q2 2026, its #756 holding.
  • National Bank of Canada first reported a position in Teva Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's Teva Pharmaceuticals position peaked at $28.8M in Q4 2025.
  • 363 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.